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Introduction
Classical pituitary apoplexy is a medical emergency and 
rapid replacement with hydrocortisone may be lifesaving. 
It is caused by haemorrhage and/or infarction of a tumour 
within the pituitary gland. A high index of clinical 
suspicion is essential to diagnose this condition as prompt 
management may be life and vision saving. This guideline 
aims to take the non-specialist through the initial phase 
of assessment and management.
Clinical presentation
The diagnosis of pituitary apoplexy is often delayed as 
~80% of these patients will have no previous history 
of a pituitary problem and the clinical features mimic 
other more common neurological conditions.
 • A diagnosis of pituitary apoplexy should be considered 
in all patients who have acute severe headache and 
any of the following:
 – patients in whom subarachnoid haemorrhage 
(SAH) and meningitis have been excluded
 – patients with neuro-ophthalmic signs
 – patients with pre-existing pituitary tumours
 • Acute severe headache is the most common and 
earliest manifestation. Headache may be accompanied 
by nausea and vomiting
 • Ocular palsies, most commonly a third nerve 
palsy, can occur due to involvement of the 
cavernous sinus
 • Reduced visual acuity and visual field defects, most 
commonly a bi-temporal hemianopia, are due to optic 
chiasmal compression
 • Fever, neck stiffness, photophobia or reduced 
consciousness (similar to signs/symptoms of SAH or 
meningitis) may occur
Precipitating factors
Hypertension, major surgery, especially coronary artery 
bypass grafting, dynamic testing of the pituitary gland, 
anticoagulation therapy, coagulopathies, pregnancy and 
head trauma.
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Suspected pituitary apoplexy
Supportive measures to ensure haemodynamic stability 
Assessment and management of fluid/electrolyte balance 
Consider hydrocortisone replacement 
Urgent biochemical and endocrine assessment
(full blood count, urea and electrolytes, liver function tests clotting screen,
IGF1, GH, PRL, TSH, T4, LH, FSH, cortisol, testosterone or oestradiol)
Urgent MRI to confirm diagnosis
or
A dedicated pituitary CT scan if MRI is contraindicated
Liaise with regional endocrine and neurosurgical team
immediately after the diagnosis is confirmed 
Severely reduced visual acuity 
Severe and persistent or deteriorating visual field defects
Deteriorating level of consciousness
Consider surgical management Conservative management
Close monitoring (neurological, visual
and endocrine)
Patient stable or improving
Continue conservative management
Yes No
Consider surgical management
Yes No
Figure 1
Pituitary apoplexy emergency management summary.
DOI: 10.1530/EC-16-0057
http://www.endocrineconnections.org © 2016 Society for Endocrinology
Published by Bioscientifica Ltd
This work is licensed under a Creative Commons 
Attribution-NonCommercial-NoDerivatives 4.0 
International License.
Emergency Guidance S E Baldeweg et al. Pituitary apoplexy emergency 
guidance
En
d
o
cr
in
e 
C
o
n
n
ec
ti
o
n
s
G14–G15 5:G14
Differential diagnosis
 • SAH due to ruptured intracranial aneurysm or 
arteriovenous malformation
 • Bacterial/viral meningitis
 • Brainstem infarction
 • Cavernous sinus thrombosis
Management
 • Ensure haemodynamic stability through supportive 
measures
 • Urgent bloods: urea and electrolytes, full blood count, 
renal and liver function tests, clotting profile
 • Indications for empirical steroid therapy in patients 
with pituitary apoplexy are haemodynamic instability, 
altered consciousness level, reduced visual acuity 
and severe visual field defects. Steroid replacement is 
potentially lifesaving in these patients
 • In adults, hydrocortisone 100 mg i.m. bolus followed 
by 50–100 mg six hourly by intramuscular injec-
tion or 100–200 mg as an intravenous bolus followed 
by 2–4 mg per hour by continuous i.v. infusion can be 
used
 • Careful assessment of fluid and electrolyte balance
 • Ideally, endocrine evaluation with blood samples for 
random serum cortisol, TSH, free T4, prolactin, IGF1, 
LH, FSH, testosterone (men), oestradiol (women) for 
later analysis
 • Bedside assessment of visual acuity and fields
 • Further neuro-ophthalmic assessments can be 
undertaken when the patient is clinically stable
 • CT brain (± LP) to exclude SAH and meningitis should 
be undertaken if not already done
 • Magnetic resonance imaging (MRI) is the investigation 
of choice and has been shown to confirm the diagnosis 
in over 90% of patients. A pituitary CT is indicated if 
MRI is contraindicated or not possible
 • Urgent referral to the joint neurosurgical/endocrine 
unit for definitive management
After emergency care: where should patients 
with pituitary apoplexy be managed?
Once the diagnosis has been confirmed, it is recommended 
that all patients be transferred once medically stabilised, 
following liaison and advice from the specialist 
neurosurgical/endocrine team, to the local neurosurgical/
endocrine team as soon as possible. Neurosurgical high 
dependency unit (HDU) facilities must be available. 
This team must have access to specialist endocrine and 
ophthalmological expertise. These patients should then 
be managed according the Society for Endocrinology UK 
guidelines for the management of pituitary apoplexy (1).
Indications for surgery
Patients should first be stabilised medically with steroid 
replacement, if needed, before surgical intervention. 
Studies have shown significantly greater improvement in 
visual acuity and visual field defects in patients who had 
early surgery (within 8 days).
Surgical intervention should be considered in 
patients with:
 • Severely reduced visual acuity
 • Severe and persistent visual field defects
 • Deteriorating  level of consciousness
Long-term follow-up
All patients with pituitary apoplexy need follow-up 
by endocrine and neurosurgical teams. They require 
repeat assessment of pituitary and visual function, 
at 4–6 weeks. Thereafter, 6–12 monthly follow-up to 
optimise hormonal replacement and to monitor tumour 
progression/recurrence.
Summary
See Fig. 1 for an emergency management summary.
Pituitary apoplexy is a rare and potentially lethal 
endocrine emergency, characterised by acute severe 
headache, visual defects, and/or reduced consciousness.
The clinical presentation often mimics other more 
common neurological emergencies.
Prompt resuscitation and corticosteroid replacement 
may be lifesaving.
MRI scan is the investigation of choice.
Urgent discussion with the regional neurosurgical/
endocrine team is essential.
Surgical intervention should be considered in patients 
with severe and persisting visual defects or in those 
with deteriorating level of consciousness after medical 
stabilisation and steroid replacement.
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Disclaimer
The document should be considered as a guideline only; it is not 
intended to determine an absolute standard of medical care. The 
doctors concerned must make the management plan for an individual 
patient.
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